ææ管çæ
åœè
ã幎ïŒåçšåºŠã®åºæ¬çãªææ察çç ä¿®ã¯å®æœããŠãããã®ã®ãææè¡çã®éµå®ç¶æ³ã¯é«ããšã¯ãããªãã£ãããŸããæž
æå¡ã¯å§èšæ¥åå¥çŽã®é¢ä¿äžãCOVID-19æ£è
ã®ããªããšãªã¢ã§ã®æ¥åã«éå®ããããããåœå
ã§COVID-19ãæµè¡ããŠãããCOVID-19ã«ç¹åããææ察çç ä¿®ã¯ãããŠããªãã£ããè±åœã®å ±å3ïŒã§ã¯ãç
é¢æž
æå¡ã®è¡æž
æäœä¿æå²åãæãé«ãïŒ34.5ïŒ
ïŒãæž
æå¡ã®è¡æž
åå¿éœæ§ã®çžå¯Ÿãªã¹ã¯ã¯ãæ£è
ã®èšºçã«ãããå»çåŸäºè
ãšæ¯èŒããŠ2.34åã§ãã£ããåœå
ã§ã¯ãå§èšæ¥è
ã§ãã£ãŠãCOVID-19察å¿ã®PPEçè±æå°ãæè²ãäºåã«å®æœããéœæ§æ£è
åå
¥ããšãªã¢ã§ã®æ¥åãå®å
šã«å®æœããŠããCOVID-19åãå
¥ãæœèšããããå§èšæž
æå¡ã«å¯ŸããŠãåºæ¬çãªææ管çã®ç¥èç¿åŸãé©åãªPPEççšãææè¡çãæž
æœãªéå
·ã®ç®¡çã«é¢ããèšç·Žãããããšã§ãæ¥åäžã®ææã®å±éºãäœæžã§ãããšèããããããŸããç
é¢ã§ã¯çäŸãçãäŸããã®RIå»æ£ç©ã®éæ¬ãäœæ¥æã®PPEçè±èšç·Žããã³ææè¡ç匷åãå®æçã«ç¢ºèªããŠããä»çµã¿ãéèŠã§ããã
SARS-CoV-2ã®äž»ãªææçµè·¯ã¯é£æ²«ææã§ããããä»å確èªããã9åã®ããã«ãçŽæ¥ãŸãã¯éæ¥çãªæ¥è§Šã«ããSARS-CoV-2ææãçãããçäŸãå ±åãããŠãã2ïŒãå»çãæœèšã®çŸå Žã«ãããŠã¯ãæž æãè¡ããŸãã¯å»æ£ç©ãæ±ãè ã«å¯ŸããPPEã®é©åãªäœ¿çšãšææè¡çã«é¢ããç ä¿®ãåããããåçåŽåçãããŒã ããŒãžäžã«å ¬éããŠãããã§ãã¯ãªã¹ã4ïŒã掻çšããªããããã®åŸ¹åºçãªå®æœã確èªããŠããããšãCOVID-19ææäºé²ã«éèŠã§ããããŸããæ¥åžžç掻ã«ãããŠæž æãè¡ããŸãã¯ãŽããæ±ãå Žåã«ããé©åãªææŽãã«ããææãªã¹ã¯ãæžãããå¯èœæ§ãããã
SARS-CoV-2ã®äž»ãªææçµè·¯ã¯é£æ²«ææã§ããããä»å確èªããã9åã®ããã«ãçŽæ¥ãŸãã¯éæ¥çãªæ¥è§Šã«ããSARS-CoV-2ææãçãããçäŸãå ±åãããŠãã2ïŒãå»çãæœèšã®çŸå Žã«ãããŠã¯ãæž æãè¡ããŸãã¯å»æ£ç©ãæ±ãè ã«å¯ŸããPPEã®é©åãªäœ¿çšãšææè¡çã«é¢ããç ä¿®ãåããããåçåŽåçãããŒã ããŒãžäžã«å ¬éããŠãããã§ãã¯ãªã¹ã4ïŒã掻çšããªããããã®åŸ¹åºçãªå®æœã確èªããŠããããšãCOVID-19ææäºé²ã«éèŠã§ããããŸããæ¥åžžç掻ã«ãããŠæž æãè¡ããŸãã¯ãŽããæ±ãå Žåã«ããé©åãªææŽãã«ããææãªã¹ã¯ãæžãããå¯èœæ§ãããã